Armando Orlandi/photos.asco.org
Mar 28, 2025, 16:06
Armando Orlandi: Our new study on HER2-low luminal BC is Riding Breast Cancer’s Biggest Data’s Wave
Armando Orlandi, Medical Director at the Agostino Gemelli University Hospital Foundation IRCCS, shared a post on
“Cowabunga! Riding Breast Cancer’s Biggest Data’s Wave from Literature
Our new study on HER2-low luminal BC is making waves!
566 patients showed tricky patterns: lower pCR rates (13.2% vs 17.7%) but trending toward better survival for HER2-low.”
Authors: Giovanna Garufi, Armando Orlandi et al
Alessandra Fabi
Angelachiara Rotondi
Antonella Palazzo
Antonio Franco
Armando Orlandi
cancer
Carbognin Luisa
Elena Di Monte
Emilio Bria
Fabio Marazzi
Giampaolo Tortora
Gianluca Franceschini
Giorgia Arcuri
Giovanna Garufi
Giovanni Scambia
Ida Paris
Luca Mastrantoni
Noemi Maliziola
OncoDaily
Oncology
Valentina Frescura
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
May 10, 2025, 14:14
May 10, 2025, 14:11
May 10, 2025, 13:57